Job ID: 521447591
Job date: 2018-01-05
End Date:
Company : GigaGen Inc Country : Role : Research Scientist
Job date: 2018-01-05
End Date:
Company : GigaGen Inc Country : Role : Research Scientist
Job Description:
GigaGen seeks a talented, highly motivated Senior Scientist in Bioinformatics to work alongside laboratory scientists on research funded by a $50 million co-development deal with Grifols, plus Phase II SBIR grants from the NCI and NIAID. The project involves deep analysis of high-throughput sequencing data and massively parallel biological assays. The candidate will lead identification of novel drug targets through design and analysis of functional genomics experiments, in collaboration with laboratory personnel. The ideal candidate has a Ph.D. in Bioinformatics, Cancer Biology, or Genetics with 5+ years of experience coding in high-level languages such as Perl, Python, and R. One or more of the following specific skills could be useful:
Additional Info:
GigaGen is advancing a pipeline of first-in-class biotherapeutics, including novel oncology antibody drug combinations and the world’s first recombinant polyclonal hyperimmune gammaglobulin. Behind our diverse and growing pipeline is a mission to bring forth a new generation of highly efficacious drugs, driven by an unparalleled understanding of immune dysregulation. Our proprietary antibody discovery technology quickly characterizes every cell in complex immune systems, powering our selection of drug targets, identification of drug candidates and preclinical assessment of efficacy.[Click Here to Access the Original Job Post]
GigaGen seeks a talented, highly motivated Senior Scientist in Bioinformatics to work alongside laboratory scientists on research funded by a $50 million co-development deal with Grifols, plus Phase II SBIR grants from the NCI and NIAID. The project involves deep analysis of high-throughput sequencing data and massively parallel biological assays. The candidate will lead identification of novel drug targets through design and analysis of functional genomics experiments, in collaboration with laboratory personnel. The ideal candidate has a Ph.D. in Bioinformatics, Cancer Biology, or Genetics with 5+ years of experience coding in high-level languages such as Perl, Python, and R. One or more of the following specific skills could be useful:
- Deep experience coding high-level languages such as Perl, Python, and R.
- Practical skills in probability and statistics, for example, linear regression, design of experiments, and analysis of variance.
- Experience with visualization of complex datasets ("big data"), for example using igraph.
- Experience building, maintaining, and mining biological databases, e.g., gene expression, deep sequencing, genome annotation.
- Comforrable computing in command line Linux environment, preferably with skills in system administration.
- Knowledge of cancer biology, cell biology, and immunology, i.e., ability to read and understand technical literature and interact closely with laboratory teams.
- Excellent writing and presentation skills.
- Experience, desire, and/or interest in drug discovery and development, with a particular focus on biologics.
- Creative approach to problem solving and ability to learn new skills
- MS or PhD degree in Bioinformatics, Cancer Biology, Genetics, or related discipline from a respected research university (MIT, Harvard, Berkeley, Stanford, UC, etc)
- Serious ambition and keen intellect
- High-level intellectual interests rather than a focus on a particular molecular or cellular pathway, or even a particular technology
- Not afraid of expressing your ideas
Requeriments :
Skills :
- Cancer biology
- Cell Biology
- immunology
- Lunix/Unix
- Programing in Python
- Programming in PERL
- Programming in R
- Statistics
Areas :
Additional Info:
GigaGen is advancing a pipeline of first-in-class biotherapeutics, including novel oncology antibody drug combinations and the world’s first recombinant polyclonal hyperimmune gammaglobulin. Behind our diverse and growing pipeline is a mission to bring forth a new generation of highly efficacious drugs, driven by an unparalleled understanding of immune dysregulation. Our proprietary antibody discovery technology quickly characterizes every cell in complex immune systems, powering our selection of drug targets, identification of drug candidates and preclinical assessment of efficacy.[Click Here to Access the Original Job Post]